The Institute of Inflammation, Immunology and Infectious Disease at Purdue University has partnered with Cleveland-based technology firm IdentifySensors Biologics to develop a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, the virus that causes COVID-19.
The platform technology can be easily modified to also detect influenza, Zika, dengue, HIV/AIDS, hepatitis C, Lyme disease, mumps, measles, chickenpox, methicillin-resistant staphylococcus Aureus (MRSA) and foodborne pathogens.
The technology is based on the work of Lia Stanciu, professor of materials engineering at Purdue, who developed the technique of identifying pathogens by their induced distinctive resistance change to electronic materials.
An ASIC chip with an array of sensors
Nano-channel | Perforated MOS sensor
SEM image of the perforated MOS sensor
The researchers are looking for partners to continue developing their technology.
For more information on licensing and other opportunities, contact Matthew Halladay of OTC at mrhalladay@prf.org and mention track code:
2013-MOHA-66407
